CADASIL in central Italy: a retrospective clinical and genetic study in 229 patients

• Published in: Journal of neurology Vol. 262; no. 1; pp. 134 - 141
• Main Authors: Bianchi, Silvia, Zicari, Enza, Carluccio, Alessandra, Di Donato, Ilaria, Pescini, Francesca, Nannucci, Serena, Valenti, Raffaella, Ragno, Michele, Inzitari, Domenico, Pantoni, Leonardo, Federico, Antonio, Dotti, Maria Teresa
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.01.2015; Springer Nature B.V
• Subjects: Adult; Aged; CADASIL - epidemiology; CADASIL - genetics; CADASIL - physiopathology; Cognitive ability; Convulsions & seizures; Dementia; Disease; Epidermal growth factor; Female; Genotype; Genotype & phenotype; Humans; Hypertension; Ischemia; Italy - epidemiology; Male; Medicine; Medicine & Public Health; Middle age; Middle Aged; Migraine; Mutation; Mutation - genetics; Neurology; Neuroradiology; Neurosciences; Original Communication; Patients; Phenotype; Population; Receptor, Notch3; Receptors, Notch - genetics; Retrospective Studies; Stroke; Italy; Clinical spectrum; CADASIL; Prevalence; gene
• ISSN: 0340-5354; 1432-1459; 1432-1459
• DOI: 10.1007/s00415-014-7533-2

The objective of the study is to detail clinical and NOTCH3 gene mutational spectrum in a large group of Italian CADASIL patients. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a familial cerebral small vessels disease caused by mutations in the NOTCH3 gene on 19p13 usually presenting in young or middle adulthood. Characteristic features include migraine, recurrent lacunar stroke, subcortical dementia, mood disturbances and leukoencephalopathy. The disorder is often overlooked and misdiagnosed. CADASIL prevalence and disease burden is still undetermined. We retrospectively reviewed demographic, clinical, and mutational characteristic of all CADASIL patients diagnosed from January 2002 to December 2012 in three referral centers for neurogenetic and cerebrovascular diseases in central Italy. 229 NOTCH3 positive subjects were identified. Mean age at diagnosis was 57.8 ± 14.7 years, and 48.6 ± 17.1 years at first symptom onset. Most frequent clinical symptoms were ischemic events (59 %) and psychiatric disturbances (48 %). The highest percentage of mutations were found on exons 4 and 19 (20.6 and 17.6 % respectively), the remaining being dispersed over the entire EGF-like region of the NOTCH3 gene. 209 patients resided in a circumscribed geographic area which included three regions of the central Italy, yielding a minimum prevalence of 4.1 per 100.000 adult inhabitants. This is the most extensive study on CADASIL in Italy. Clinical phenotype showed several peculiarities in frequency and presentation of the main disease manifestations. Our study enlarges the number of pathogenic NOTCH3 mutations and due to the heterogeneous mutational spectrum observed suggests that full sequencing of exons 2–24 is mandatory for CADASIL screening in the Italian population.